Sagimet Biosciences Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 10.43 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 739.58M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Details
| Name | Sagimet Biosciences Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 16 |
| Founded | 2006 |
| Ipo Date | 2023-07-14 |
| Ceo | David Happel |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US7867001049 |
| Cusip | 786700104 |
| Cik | 1400118 |
| Sic | 2834 |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| David A. Happel | Chief Executive Officer, President and Director |
| Elizabeth Rozek Esq., J.D. | Chief Legal and Administrative Officer |
| Urs Greber Ph.D. | Co-Founder |
| Dr. Lucas Pelkmans Ph.D. | Co-Founder |
| Thierry Chauche | Chief Financial Officer and Principal Accounting Officer |
| Dr. Marie O'Farrell Ph.D. | Chief Scientific Officer |
| Robert D'Urso | Senior Vice President of New Products |
| Dr. Andreas Grauer M.D. | Chief Medical Officer |
Contact
| Address | 155 Bovet Road, Suite 303, San Mateo, California 94402, United States |
| Phone | 650 561 8600 |
| Website | https://www.sagimet.com |